{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:14:09Z","timestamp":1793369649787,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03780-8","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:31:25Z","timestamp":1743017485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Relationship between anthropometric measures and the risk of incident Metabolic dysfunction-associated steatotic liver disease: a longitudinal study"],"prefix":"10.1186","volume":"25","author":[{"given":"Takahiro","family":"Ichikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Obora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahide","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"6","key":"3780_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"issue":"5","key":"3780_CR2","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","volume":"80","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Paik JM, Stepanova M, Ong J, Alqahtani S, Henry L. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J Hepatol. 2024;80(5):694\u2013701. https:\/\/doi.org\/10.1016\/j.jhep.2024.01.014.","journal-title":"J Hepatol"},{"issue":"2","key":"3780_CR3","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","volume":"80","author":"H Hagstr\u00f6m","year":"2024","unstructured":"Hagstr\u00f6m H, Vessby J, Ekstedt M, Shang Y. 99% of patients with NAFLD Meet MASLD criteria and natural history is therefore identical. J Hepatol. 2024;80(2):e76\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.026.","journal-title":"J Hepatol"},{"issue":"8","key":"3780_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metabolism. 2024;35(8):697\u2013707. https:\/\/doi.org\/10.1016\/j.tem.2024.02.007.","journal-title":"Trends Endocrinol Metabolism"},{"key":"3780_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14276","author":"BG Zhou","year":"2024","unstructured":"Zhou BG, Jiang X, She Q, Ding YB. Association of MASLD with the risk of extrahepatic cancers: A systematic review and meta-analysis of 18 cohort studies. Eur J Clin Invest Published Online. 2024. https:\/\/doi.org\/10.1111\/eci.14276.","journal-title":"Eur J Clin Invest Published Online"},{"key":"3780_CR6","doi-asserted-by":"publisher","unstructured":"Sidhu PS, Fang C. Us-based hepatic fat quantification: an emerging technique and game changer? Radiology. 2023;307(1). https:\/\/doi.org\/10.1148\/radiol.223002.","DOI":"10.1148\/radiol.223002"},{"issue":"4","key":"3780_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jceh.2017.05.005","volume":"7","author":"A Singh","year":"2017","unstructured":"Singh A, Parida S, Narayan J, et al. Simple anthropometric indices are useful for predicting Non-alcoholic fatty liver disease [NAFLD] in Asian Indians. J Clin Exp Hepatol. 2017;7(4):310\u20135. https:\/\/doi.org\/10.1016\/j.jceh.2017.05.005.","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"3780_CR8","doi-asserted-by":"publisher","first-page":"E2415051","DOI":"10.1001\/jamanetworkopen.2024.15051","volume":"7","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ma N, Lin Q, et al. Body roundness index and All-Cause mortality among US adults. JAMA Netw Open. 2024;7(6):E2415051. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.15051.","journal-title":"JAMA Netw Open"},{"key":"3780_CR9","doi-asserted-by":"publisher","unstructured":"Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE. 2012;7(7). https:\/\/doi.org\/10.1371\/journal.pone.0039504.","DOI":"10.1371\/journal.pone.0039504"},{"issue":"12","key":"3780_CR10","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1210\/clinem\/dgae282","volume":"109","author":"M Kajikawa","year":"2024","unstructured":"Kajikawa M, Maruhashi T, Kishimoto S, et al. A body shape index as a simple anthropometric marker of abdominal obesity and risk of cardiovascular events. J Clin Endocrinol Metab. 2024;109(12):3272\u201381. https:\/\/doi.org\/10.1210\/clinem\/dgae282.","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"3780_CR11","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.3390\/nu15132943","volume":"15","author":"N Yang","year":"2023","unstructured":"Yang N, Zhuo J, Xie S, et al. A body shape index and its changes in relation to All-Cause mortality among the Chinese elderly: A retrospective cohort study. Nutrients. 2023;15(13):2943. https:\/\/doi.org\/10.3390\/nu15132943.","journal-title":"Nutrients"},{"issue":"5","key":"3780_CR12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/obr.12666","volume":"19","author":"M Ji","year":"2018","unstructured":"Ji M, Zhang S, An R. Effectiveness of A body shape index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis. Obes Rev. 2018;19(5):737\u201359. https:\/\/doi.org\/10.1111\/obr.12666.","journal-title":"Obes Rev"},{"key":"3780_CR13","doi-asserted-by":"publisher","unstructured":"Li Y, He Y, Yang L, et al. Body roundness index and Waist\u2013Hip ratio result in better cardiovascular disease risk stratification: results from a large Chinese Cross-Sectional study. Front Nutr. 2022;9. https:\/\/doi.org\/10.3389\/fnut.2022.801582.","DOI":"10.3389\/fnut.2022.801582"},{"issue":"1","key":"3780_CR14","doi-asserted-by":"publisher","first-page":"e23429","DOI":"10.1016\/j.heliyon.2023.e23429","volume":"10","author":"E Zhao","year":"2024","unstructured":"Zhao E, Wen X, Qiu W, Zhang C. Association between body roundness index and risk of ultrasound-defined non-alcoholic fatty liver disease. Heliyon. 2024;10(1):e23429. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23429.","journal-title":"Heliyon"},{"issue":"10","key":"3780_CR15","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.5152\/tjg.2023.23101","volume":"34","author":"X Tian","year":"2023","unstructured":"Tian X, Ding N, Su Y, Qin J. Comparison of Obesity-Related indicators for nonalcoholic fatty liver disease diagnosed by transient elastography. Turkish J Gastroenterol. 2023;34(10):1078\u201387. https:\/\/doi.org\/10.5152\/tjg.2023.23101.","journal-title":"Turkish J Gastroenterol"},{"issue":"1","key":"3780_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12944-022-01717-8","volume":"21","author":"M Kuang","year":"2022","unstructured":"Kuang M, Sheng G, Hu C, Lu S, Peng N, Zou Y. The value of combining the simple anthropometric obesity parameters, body mass index (BMI) and a body shape index (ABSI), to assess the risk of non-alcoholic fatty liver disease. Lipids Health Dis. 2022;21(1):104. https:\/\/doi.org\/10.1186\/s12944-022-01717-8.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"3780_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/jgh.12786","volume":"30","author":"Y Hashimoto","year":"2015","unstructured":"Hashimoto Y, Hamaguchi M, Kojima T, et al. The modest alcohol consumption reduces the incidence of fatty liver in men: A population-based large-scale cohort study. J Gastroenterol Hepatol (Australia). 2015;30(3):546\u201352. https:\/\/doi.org\/10.1111\/jgh.12786.","journal-title":"J Gastroenterol Hepatol (Australia)"},{"issue":"10","key":"3780_CR18","doi-asserted-by":"publisher","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","volume":"143","author":"M Hamaguchi","year":"2005","unstructured":"Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143(10):722. https:\/\/doi.org\/10.7326\/0003-4819-143-10-200511150-00009.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3780_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1373\/clinchem.2006.078980","volume":"53","author":"S Ryu","year":"2007","unstructured":"Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. \u03b3-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem. 2007;53(1):71\u20137. https:\/\/doi.org\/10.1373\/clinchem.2006.078980.","journal-title":"Clin Chem"},{"issue":"11","key":"3780_CR20","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/oby.20408","volume":"21","author":"DM Thomas","year":"2013","unstructured":"Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity. 2013;21(11):2264\u201371. https:\/\/doi.org\/10.1002\/oby.20408.","journal-title":"Obesity"},{"issue":"12","key":"3780_CR21","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708\u201315. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01526.x.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"3780_CR22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics. 1988;44(3):837. https:\/\/doi.org\/10.2307\/2531595.","journal-title":"Biometrics"},{"key":"3780_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","volume":"122","author":"V Lekakis","year":"2024","unstructured":"Lekakis V, Papatheodoridis GV. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur J Intern Med. 2024;122:3\u201310. https:\/\/doi.org\/10.1016\/j.ejim.2023.11.005.","journal-title":"Eur J Intern Med"},{"key":"3780_CR24","doi-asserted-by":"publisher","first-page":"155789","DOI":"10.1016\/j.metabol.2024.155789","volume":"152","author":"E Han","year":"2024","unstructured":"Han E, Lee BW, Kang ES, et al. Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study. Metabolism. 2024;152:155789. https:\/\/doi.org\/10.1016\/j.metabol.2024.155789.","journal-title":"Metabolism"},{"issue":"9793","key":"3780_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","volume":"378","author":"BA Swinburn","year":"2011","unstructured":"Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(11)60813-1.","journal-title":"Lancet"},{"key":"3780_CR26","doi-asserted-by":"publisher","first-page":"155217","DOI":"10.1016\/j.metabol.2022.155217","volume":"133","author":"C Boutari","year":"2022","unstructured":"Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to Rage on. Metabolism. 2022;133:155217. https:\/\/doi.org\/10.1016\/j.metabol.2022.155217.","journal-title":"Metabolism"},{"issue":"1","key":"3780_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1\u20134. https:\/\/doi.org\/10.1172\/JCI92035.","journal-title":"J Clin Invest"},{"issue":"7121","key":"3780_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nature05487","volume":"444","author":"LF Van Gaal","year":"2006","unstructured":"Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875\u201380.","journal-title":"Nature"},{"key":"3780_CR29","doi-asserted-by":"publisher","unstructured":"Maldonado-Rojas A, del Zuarth-V\u00e1zquez C, Uribe JM, Barbero-Becerra M. Insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD): pathways of action of hypoglycemic agents. Ann Hepatol. 2024;29(2). https:\/\/doi.org\/10.1016\/j.aohep.2023.101182.","DOI":"10.1016\/j.aohep.2023.101182"},{"issue":"1","key":"3780_CR30","doi-asserted-by":"publisher","first-page":"e000741","DOI":"10.1136\/bmjdrc-2019-000741","volume":"8","author":"J Jiang","year":"2020","unstructured":"Jiang J, Cai X, Pan Y, et al. Relationship of obesity to adipose tissue insulin resistance. BMJ Open Diabetes Res Care. 2020;8(1):e000741. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000741.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3780_CR31","doi-asserted-by":"publisher","unstructured":"Behari J, Wang R, Luu HN, McKenzie D, Molinari M, Yuan JM. Severe obesity is associated with worse outcomes than lean metabolic dysfunction\u2013associated steatotic liver disease. Hepatol Commun. 2024;8(7). https:\/\/doi.org\/10.1097\/HC9.0000000000000471.","DOI":"10.1097\/HC9.0000000000000471"},{"key":"3780_CR32","unstructured":"Obesity and overweight. Accessed August 24. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"issue":"3","key":"3780_CR33","doi-asserted-by":"publisher","first-page":"EJ23","DOI":"10.1507\/endocrj.EJ23-0593","volume":"71","author":"W Ogawa","year":"2024","unstructured":"Ogawa W, Hirota Y, Miyazaki S, et al. Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan. Endocr J. 2024;71(3):EJ23\u20130593. https:\/\/doi.org\/10.1507\/endocrj.EJ23-0593.","journal-title":"Endocr J"},{"issue":"7","key":"3780_CR34","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2337\/dc06-0057","volume":"29","author":"I Shai","year":"2006","unstructured":"Shai I, Jiang R, Manson JE, et al. Ethnicity, obesity, and risk of type 2 diabetes in women. Diabetes Care. 2006;29(7):1585\u201390. https:\/\/doi.org\/10.2337\/dc06-0057.","journal-title":"Diabetes Care"},{"issue":"s1","key":"3780_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1467-789X.2007.00439.x","volume":"9","author":"R Huxley","year":"2008","unstructured":"Huxley R, James WPT, Barzi F, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev. 2008;9(s1):53\u201361. https:\/\/doi.org\/10.1111\/j.1467-789X.2007.00439.x.","journal-title":"Obes Rev"},{"issue":"9","key":"3780_CR36","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1002\/hep4.1981","volume":"6","author":"E Truong","year":"2022","unstructured":"Truong E, Yeo YH, Cook-Wiens G, et al. Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the National health and nutrition examination surveys 2017\u20132018. Hepatol Commun. 2022;6(9):2253\u201361. https:\/\/doi.org\/10.1002\/hep4.1981.","journal-title":"Hepatol Commun"},{"key":"3780_CR37","doi-asserted-by":"publisher","unstructured":"Motamed N, Rabiee B, Hemasi GR, et al. Body roundness index and Waist-to-Height ratio are strongly associated with Non-Alcoholic fatty liver disease: A Population-Based study. Hepat Mon. 2016;16(9). https:\/\/doi.org\/10.5812\/hepatmon.39575.","DOI":"10.5812\/hepatmon.39575"},{"issue":"5","key":"3780_CR38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.orcp.2023.09.005","volume":"17","author":"JH Lee","year":"2023","unstructured":"Lee JH, Jeon S, Lee HS, Kwon YJ. Association between waist circumference trajectories and incident non-alcoholic fatty liver disease. Obes Res Clin Pract. 2023;17(5):398\u2013404. https:\/\/doi.org\/10.1016\/j.orcp.2023.09.005.","journal-title":"Obes Res Clin Pract"},{"issue":"6","key":"3780_CR39","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/hepr.14011","volume":"54","author":"K Suzuki","year":"2024","unstructured":"Suzuki K, Tamaki N, Kurosaki M, et al. Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease. Hepatol Res. 2024;54(6):600\u20135. https:\/\/doi.org\/10.1111\/hepr.14011.","journal-title":"Hepatol Res"},{"issue":"1","key":"3780_CR40","first-page":"47","volume":"23","author":"SL Wong","year":"2012","unstructured":"Wong SL, Shields M, Leatherdale S, Malaison E, Hammond D. Assessment of validity of self-reported smoking status. Health Rep. 2012;23(1):47\u201353.","journal-title":"Health Rep"},{"issue":"s2","key":"3780_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1359-6357.2003.00586.x","volume":"98","author":"FK Del Boca","year":"2003","unstructured":"Del Boca FK, Darkes J. The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction. 2003;98(s2):1\u201312. https:\/\/doi.org\/10.1046\/j.1359-6357.2003.00586.x.","journal-title":"Addiction"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03780-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03780-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03780-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:31:40Z","timestamp":1743017500000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03780-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3780"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03780-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for the present research project was approved by Asahi University Hospital Ethics Committee, (approval number:2018-09-01) in accordance with the provisions of the Declaration of Helsinki. Informed consent was obtained from all participants and\/or their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ichikawa T grants from Abbott Japan Co. Ltd. Hashimoto Y received personal fees from Novo Nordisk Pharma Ltd., Sanofi K.K., Sumitomo Dainippon Pharma Co., Ltd., Nippon Boehringer Ingelheim Co., Mitsubishi Tanabe Pharma Corp., Kowa Company, Ltd., Taisho Pharma Co., Eli Lilly Japan K.K. and Daiichi Sankyo Co. Hamaguchi M received grants from AstraZeneca K.K., Ono Pharma Co. Ltd., Kowa Pharma Co. Ltd. Fukui M received grants from Ono Pharma Co. Ltd., Oishi Kenko inc., Yamada Bee Farm, Nippon Boehringer Ingelheim Co. Ltd., Kissei Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corp., Daiichi Sankyo Co. Ltd., Sanofi K.K., Takeda Pharma Co. Ltd., Astellas Pharma Inc., MSD K.K., Kyowa Kirin Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Kowa Pharma Co. Ltd., Novo Nordisk Pharma Ltd., Sanwa Kagagu Kenkyusho CO., Ltd., Eli Lilly, Japan, K.K., Taisho Pharma Co., Ltd., Terumo Corp., Tejin Pharma Ltd., Nippon Chemiphar Co., Ltd., Abbott Japan Co. Ltd., and Johnson & Johnson K.K. Medical Co., TERUMO CORPORATION. All authors\u2019 grants were outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"202"}}